Bimuno IMMUNAID Prebiotic Supplements

Bimuno ImmunAid

Information for Healthcare Professionals: Bimuno IMMUNAID is designed to work in harmony with the body’s natural defences. It is intended to increase and strengthen the body’s immunity boosting Bifidobacteria.

The Clinical Challenge

A number of factors can compromise your patients’ positive bacterial balance and immune system. These include stress, poor diet, infection (including hospital acquired infections), ageing and the use of antibiotics.

The ageing process leads to a reduction in beneficial and increase in harmful bacteria and a subsequent marked decline in immune function (immunosenescence), which can promote hyporesponsiveness to vaccination and a predisposition to infectious and non-infectious diseases1.

Antibiotic Associated Diarrhoea (AAD), results from the disruption of the normal bacterial balance caused by antibiotics thus enabling the overgrowth of harmful bacteria such as C.difficile2. AAD occurs in up to 30% of patients either early during antibiotic therapy or up to two months after end of treatment3,4.

More about Bimuno® IMMUNAID

Bimuno® IMMUNAID is designed to work in harmony with the body’s natural defences. It is intended to increase and strengthen the body’s immunity boosting Bifidobacteria.

It is formulated to provide an improved Bimuno® product which combines the unique B-GOS prebiotic properties with the added benefit of vitamin C in an easy to use, discreet pastille format.

It is scientifically proven to energise the body’s immunity boosting bacteria (Bifidobacteria)5.
It is also clinically proven to help maintain a healthy immune function in the elderly
6. Over the age of 55 Bifidobacterial levels, which are essential in stimulating the body’s immune cells, begin to decline and this has a negative effect on gut and immune health. The older we become, the less Bifidobacteria we have.

The Scientific Evidence

Energising the body’s immunity boosting bacteria (Bifidobacteria):

• Bimuno® significantly increased the numbers of beneficial bacteria, especially Bifidobacteria5

• It’s prebiotic (increase and strengthening in beneficial bacteria) and bifidogenic (increase and strengthening in Bifidobacteria) effect was superior to 1st generation GOS prebiotics5

• Bimuno® significantly increased bifidobacteria within a week5.

Maintaining Healthy Immune Function in the Elderly:

• Bimuno® significantly increased the numbers of beneficial bacteria, especially Bifidobacteria, at the expense of less beneficial groups compared with baseline and placebo6

• It had a direct positive effect on the innate immune system by significantly increasing phagocytic and NK cell activity6

• It had a direct positive effect on the adaptive immune system by increasing production of anti-inflammatory cytokine interleukin-10 (IL-10) and significantly reducing the production of pro-inflammatory cytokines (IL-6, IL-1β, and tumour necrosis factor-α)6.

Who can benefit from Bimuno® IMMUNAID?

It is ideal for those wishing to help maintain their immune health.

Recommending Bimuno® IMMUNAID

Bimuno® IMMUNAID is classed as a food supplement and does not have any of the warnings and contra-indications associated with medicinal products. It is not a medicinal product and is not intended to treat or prevent medical conditions or their symptoms.

Although no adverse effects have been reported, it should be noted that Bimuno® IMMUNAID contains small amounts of lactose (from milk).

The product contains 30 chewable pastilles and the active ingredients are galacto-oligosaccharides equivalent to a daily dose of 1.38g and also Vitamin C equivalent to a daily dose of 12mg. It is free from artificial colours, flavours and preservatives and is gluten free. The lactose content is 0.36g* per daily dose. Per daily dose it contains 13 kcal, 1.6g of sugar and 0.0g of fat.

It is suitable for children aged 4 years and over and for adults.

The dosage is two pastilles per day. For best results the two pastilles should be taken after breakfast: take one pastille immediately after the other. Since the benefits build over time, a daily intake is recommended.

Reference:
1. Aspinal R et al. Biochem Soc Trans 2000;28:250-4.
2. Barlett JG et al. N Engl J Med 1978;298:531-534.
3. Wilstrom J et al. J Antimicrob Chemother 2001;47:43-50.
4. McFarland LV. Dig Dis 1998;16:292-307.
5. Depeint F et al. Am J Clin Nutr 2008;87:785-91.
6. Vulevic J et al. Am J Clin Nutr 2008;88:1438-46.

* Lactose doses of less than 12g per day are likely to be tolerated by most of the population of lactose deficient adults. EFSA Journal (2007) 565,1-6 and EFSA Journal 1010;8(9):1777.

 

Disclaimer

This section is an information and educational resource for healthcare professionals, scientists, researchers and journalists. It is not intended for consumers. If you wish to purchase Bimuno please click here

Back to the top